Becoming a supplier
We strive to provide quality products and services that best serve our business needs and patients where the measurements are cost, quality, and outcomes.
When doing business with suppliers, the Supply Chain Organization (SCO) strives for characteristics that we believe make good business relationships including the following:
- Commitment to processes that support managing total costs, quality initiatives, and customer service
- Development of enhanced business relationships, as appropriate, with suppliers who are practicing performance management and process improvement
Are you interested in having us review your product or service? Please register for a profile with the link below. By registering for a supplier profile, it does not guarantee a business opportunity, place your company on an approved vendor list, or obligate Intermountain Healthcare to solicit requests for bids, quotations, or proposals.
Pharmacy Suppliers
To fulfill Intermountain Healthcare’s vision of being “a model health system by providing extraordinary care and superior service at an affordable cost,” medication samples and industry-based pharmaceutical reps are not allowed in clinics. Pharmaceutical reps are only allowed in clinics for non-medical items such as medical devices, oxygen, infant formula, and other non-medication items.
FAQ
Pharmacy supplier frequently asked questions
Suppliers conducting business with Intermountain Healthcare are required to register, complete an orientation, and watch the informative videos to the right.
Suppliers must log onto symplr in order to:
- Create an account.
- Fax and/or upload Intermountain-required compliance documents.
- View orientation training and complete required questions.
- Review visitation and selling privileges.
- Prior to each facility visit, representatives must:
- Have an appointment.
- Check in via symplr to obtain an appropriate access badge.
A symplr annual credentialing subscription fee may apply to suppler representatives participating in patient care. For questions and help, go to symplr's website or call (866) 373-9725.
Videos:
Generally, new drugs approved by the U.S. Food and Drug Administration will not be reviewed until they have been available on the market at least 6-12 months (unique clinical exceptions may apply).
Once a formulary decisions is made, the Pharmacy and Therapeutics Committee will not re-evaluate the drug or drug class for another two years, unless there are significant changes in drug safety or efficacy that would prompt a second review.
Contact us
7302 S. Bingham Junction Blvd.
Midvale, UT 84047
Phone: (801) 442-3300